Indian Frankincense Information & Purchase
Also Known As:
Arbre à Encens, Arbre à Oliban Indien, Boswella, Boswellia, Boswellie, Boswellin, Boswellin Serrata Resin, Encens Indien, Franquincienso, Gajabhakshya, Indian Olibanum, Oliban Indien, Resina Boswelliae, Salai Guggal, Salai Guggul, Sallaki Guggul, Shallaki, Ru Xiang.
CAUTION: See separate listings for Frankincense and Guggul.
Boswellia serrata. Family: Burseraceae.
People Use This For:
Orally, Indian frankincense is used for osteoarthritis, rheumatoid arthritis (RA), rheumatism, bursitis, and tendonitis. Other uses include ulcerative colitis,
abdominal pain, asthma, allergic rhinitis, sore throat, syphilis, painful menstruation, pimples, and cancer. It is also used as a stimulant, respiratory antiseptic, diuretic, and for stimulating menstrual flow.
In manufacturing, Indian frankincense resin oil and extracts are used in soaps, cosmetics, foods, and beverages.
LIKELY SAFE ...when used orally and appropriately. Indian frankincense has been safely used in several clinical trials lasting up to 90 days.
PREGNANCY AND LACTATION: LIKELY SAFE ...when used orally in amounts commonly found in foods. There is insufficient reliable information available about the safety of using Indian frankincense in medicinal amounts.
Osteoarthritis. Some clinical research shows that taking specific Indian frankincense extracts can reduce symptoms of osteoarthritis. In two clinical trials, using a specific Indian frankincense extract (5-Loxin) 100 mg daily or 250 mg daily significantly improved pain and functionality scores in patients with osteoarthritis after 90 days of treatment. Pain scores were reduced by about 32% to 65%. Patients began to have significant improvement within 7 days of treatment. The extract used in this study was standardized and enriched to contain 30% of the boswellic acid AKBA. One clinical trial evaluated another specific Indian frankincense extract (Aflapin) 100 mg daily. This extract significantly improved pain and functionality scores in patients with osteoarthritis after 90 days of treatment. Pain scores were reduced by about 47%. Patients began to have significant improvement within 7 days of treatment. The extract used in this study was standardized and enriched to contain 20% of the boswellic acid AKBA.
In a preliminary crossover trial, taking a different Indian frankincense extract 333 mg daily also significantly reduced symptoms of osteoarthritis, such as knee pain and swelling.
Ulcerative colitis. Two clinical trials show that taking Indian frankincense can improve some symptoms of ulcerative colitis and some pathological measures. In one study, taking Indian frankincense 350 mg three times daily significantly improved symptoms and disease markers in patients with ulcerative colitis. In this study, about 82% of patients taking Indian frankincense went into remission compared to 75% taking sulfasalazine. In another preliminary clinical study, taking Indian frankincense 300 mg three times for 6 weeks improved symptoms and some measures of disease pathology in about 90% of patients. In this study 70% of patients taking Indian frankincense went into remission compared to 40% taking sulfasalazine 3 grams daily.
INSUFFICIENT RELIABLE EVIDENCE to RATE
Asthma. There is some preliminary evidence that taking Indian frankincense extract orally might help asthma. It may improve force expiratory volume (FEV), reduce the number of asthma attacks, and decrease dyspnea and rhonchi.
Crohn's disease. There is preliminary evidence that taking Indian frankincense extract orally might reduce some symptoms of inflammatory bowel disease. One clinical study found that it worked as well as mesalamine (Asacol, Pentasa) for Crohn's disease; however, other clinical research shows that taking Indian frankincense 800 mg orally three times a day did not increase rates of remissions and quality of life any more than placebo in patients with Crohn's disease.
Rheumatoid arthritis. There is conflicting research about the usefulness of Indian frankincense extract taken orally for rheumatoid arthritis. More evidence is needed to rate Indian frankincense for these uses.
Mechanism of Action:
The applicable part of Indian frankincense is the gum resin. The gum resin is obtained by pulling away the bark of the Indian frankincense tree.
The principle constituents of Indian frankincense are boswellic acid and alpha- and beta-boswellic acid, which are thought to have anti-inflammatory properties. The 3-O-acetyl-11-keto-beta-boswellic acid (AKBA) constituent appears to be the most potent anti-inflammatory constituent.
The gum resin also contains up to 16% essential oils including alpha-thujene and p-cymene.
In preliminary research, some Indian frankincense extracts show anti-inflammatory, analgesic, and anti-arthritis effects; however, not all Indian frankincense-containing products seem to have these effects.
Boswellic acids, especially AKBA, inhibit 5-lipoxygenase and reduce leukotriene synthesis and inhibit leukocyte elastase, which are the likely mechanisms for its anti-inflammatory properties. Boswellic acids also might have disease modifying effect, decreasing glycosaminoglycan degradation and cartilage damage. Indian frankincense also might inhibit mediators of autoimmune disorders. It seems to reduce production of antibodies and cell-mediated immunity.
Indian frankincense might be useful in treating cancer. Preliminary research suggests that boswellic acids have an antiproliferative and apoptotic effect on cancer cells. Preliminary research suggests boswellic acids stabilize mast cells, which suggests usefulness for asthma. Other preliminary research suggests that boswellic acids might prevent organ rejection and ischemia/reperfusion injury.
Indian frankincense has an elimination half-life of 6 hours.
Orally, Indian frankincense is well-tolerated. Side effects reported in clinical trials did not occur more commonly than placebo. Some reported side effects include diarrhea, nausea, abdominal pain, and heartburn. No serious adverse events have been documented.
Topically, Indian frankincense can cause contact dermatitis.
Interactions with Herbs & Supplements:
Interactions with Drugs:
Interactions with Foods:
Interactions with Lab Tests:
Interactions with Diseases or Conditions:
ORAL: For osteoarthritis, a specific Indian frankincense extract (5-Loxin) 100 mg daily or 250 mg daily has been used. Indian frankincense extract 333 mg three times daily has been used.
For rheumatoid arthritis, Indian frankincense extract 3600 mg daily has been used.
For Crohn's disease, 800 mg three times daily has been used.
For ulcerative colitis, a gum resin preparation of 300-350 mg three times daily has been used.
For asthma, 300 mg three times daily has been used.
Indian frankincense is a branching tree native to India and Arabia. Indian frankincense is commonly used in traditional Indian medicine, Ayurveda, for a variety of indications.
Olibanum is another word for frankincense. It refers to the oleogum resin exuded from incisions in the bark of several Boswellia species, including Boswellia serrata, Boswellia carterii, and Boswellia frereana. Of these, Boswellia serrata is most commonly used medicinally.
General Certificate Of Analysis (COA) less manufacture date and batch number provided for different product strengths if the link is not available or manufacture date and batch number is required use the email us box to request Certificate Of Analysis (COA) emailed. Any questions about product or wholesale pricing for twenty five kilos or more. Please be sure to use product ID, Trade Name and Scientific Name.
- Specification Sheet Indian Frankincense Powder
- Specification Sheet Indian Frankincense Powder Extract 65%
Purchase Gift Certificate
"These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease."